Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AUPH | US
0
0%
Healthcare
Biotechnology
30/06/2024
04/10/2024
7.12
7.08
7.16
6.99
Aurinia Pharmaceuticals Inc. a commercial-stage biopharmaceutical company focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co. Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria Canada.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
26.1%1 month
45.3%3 months
48.3%6 months
43.5%-
15.11
2.85
0.24
0.16
-7.69
3.85
-
-27.15M
1.02B
1.02B
-
-0.77
-
37.80
-13.30
4.99
5.33
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.64
Range1M
1.02
Range3M
2.25
Rel. volume
0.62
Price X volume
5.64M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
immatics biotechnologies GmbH | IMTX | Biotechnology | 10.86 | 1.12B | 3.23% | n/a | 0.00% |
Relay Therapeutics Inc. | RLAY | Biotechnology | 6.53 | 1.06B | 0.62% | n/a | 7.50% |
Autolus Therapeutics Plc | AUTL | Biotechnology | 3.98 | 1.06B | 0.25% | n/a | 54.69% |
AnaptysBio Inc | ANAB | Biotechnology | 33.98 | 1.03B | -2.91% | n/a | 3835.68% |
Pharvaris B.V | PHVS | Biotechnology | 18.2 | 982.94M | -0.66% | n/a | 0.04% |
Array BioPharma Inc | ARRY | Biotechnology | 6.45 | 979.92M | 0.62% | 67.30 | 117.68% |
Sana Biotechnology Inc. Common Stock | SANA | Biotechnology | 4.23 | 941.03M | -2.98% | n/a | 29.02% |
Silence Therapeutics plc | SLN | Biotechnology | 18.64 | 933.49M | 1.30% | n/a | 0.16% |
Prothena Corporation plc | PRTA | Biotechnology | 16.86 | 906.74M | 1.08% | n/a | 2.08% |
Zymeworks Inc | ZYME | Biotechnology | 12.57 | 893.07M | 1.45% | n/a | 4.94% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.69 | 0.76 | Cheaper |
Ent. to Revenue | 3.85 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 2.85 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 48.30 | 74.67 | Lower Risk |
Debt to Equity | 0.24 | -1.82 | Expensive |
Debt to Assets | 0.16 | 0.26 | Cheaper |
Market Cap | 1.02B | 3.73B | Emerging |